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Summary: To assess the diagnostic value of lung scintigraphy
and helical computed tomography (hCT) in patients with sus-
pected pulmonary embolism (PE), all English-language articles
that described lung scintigraphy and hCT in patients with sus-
pected PE were retrieved. Articles were assessed for strength of
methodology, based on nine a priori-defined criteria. Param-
eters of diagnostic accuracy and results of management studies
were calculated and evaluated. Lung scintigraphy is diagnostic
in approximately 50% of patients with suspected PE. A normal
perfusion scan has a chance of recurrent PE in two of 693
patients (0.3%; 95% CI: 0.2-0.4%; fatal in 0.15%). A high-
probability lung scan is corrected with angiographically
proven PE in 308 of 350 patients (88%; 95% CI: 84-91%).
Pulmonary embolism was proven in 385 of 1529 patients (25%;
95% CI: 24-28%) with a nondiagnostic lung scan. Helical CT
studies were compared with angiography and lung scintigraphy
in 1171 patients, with a prevalence of PE of 39%. The sensi-
tivity and specificity of hCT was 283/320 (88%; 95% CI: 83-
91%) and 374/408 (92%; 95% CI:89-94%), respectively. Only
one prospective management study using hCT was available. In
patients in whom anticoagulants were withheld based on a nor-
mal hCT study, recurrent thromboembolic events occurred in
six of 109 patients (5.5%; 95% CI: 2-12%), with one fatality
(1%; 95% CI: 0.02-4.3%). Lung scintigraphy is evaluated ex-
tensively and yields a diagnostic result in 50% of patients.
Helical CT has similar positive predictive value to a high-
probability lung scan. However, the exact role of hCT in the
management of patients with suspected PE needs to be deter-
miined in prospective studies. Key Words: Helical computed
tomography&mdash;Lung scintigraphy&mdash;Putmonary embolism.
In spite of improved prophylaxis, pulmonary embo-
lism (PE) remains one of the main causes of morbidity
and mortality in the western world. Approximately two
to three patients per 1000 inhabitants are yearly sus-
pected of having PE (1-3). Adequate diagnostic tests are
required to distinguish patients who have PE from those
that have other, often nonserious, illnesses. The reason
for this diagnostic process are two-fold: the natural his-
tory ofPE (i.e., missing the diagnosis) is thought to result
in fatal and nanf~t~ recurrent PE in 30%. of patients in
category, respectively (4). On the other hand, treat-
ment with anticoagulants will result in bleeding compli-
cations, which are fatal and major in 1% and 7% per
treatment year, respectively (5,6). Thus, both underdiag-
nosis and overtreatment should be avoided.
The diagnosis traditionally depended on clinical as-
sessment. However, as demonstrated by studies that ap-
plied pulmonary angiography, the prevalence cif pulmcr-
nary embolism in patients who are clinically suspected is
only 30% (7-i l ~, Furthermore, many patients are not
diagnosed until they are seen by a pathologist (1). Hence,
the threshold for suspicion is generally low, in order to
miss as few patients as possible.
Although several noninvasive, diagnostic tests have
advocated over recent years, this overview is
limited to the assessment of the evidence for the use of
two diagnostic tests: lung scintigraphy (both perfusion
and ventilation) and the helical computed tomog-
raphy (hCT).
~~1TE LS AND METHODS
Articles were identified through the Medline database
and Current Contents, which described studies using
lung scintigraphy and hCT in patients with suspected
pulmonary embolism. The search was limited to articles
88
published in the English language, with a final inclu-
sion date of June i ; 1999. Abstracts were not included
in the analysis.
Articles were reviewed and predefined criteria were
set. Two types of publications were accepted in this
analysis: diagnostic accuracy studies and management
studies with follow-up. Several criteria, which were de-
fined a priori, needed to be met for inclusion into this ‘
analysis. These were: 1) prospective study in consecutive
patients; 2) adequate description of studied patients; 3)
sensitivity and specificity evaluation versus pulmonary
angiography; 4) blinded comparison with pulmonary an-
giography ; 5) description of imaging techniques; 6) man-
agement studies with an adequate description of how
follow-up was performed; 7) minimum follow-up of 3 ’-
months; 8) description of diagnosis in patients with re-
current symptoms; and 9) original (nonduplicated) ar-
ticles only.
Using these criteria, the two diagnostic imaging mo-
dalities were assessed for diagnostic accuracy ~i.e.; sen-
sitivity and specificity) and influence of different
observer (inter-observer variability). Finally, the evi-
dence of clinical utility in clinical practice, as demon-
strated by management studies, was evaluated.
Statistical analysis was performed by means of a pri-
mary assessment of sensitivity, specificity when com-
prison was made with pulmonary angiography and re-
current thromboembolic events in management studies.
Recurrent thromboembolic events were further subdi-
vided into fatal PE and nonfatal PE. Overall 95% confi-




Lung scintigraphy uses radioactive tracers to assess
basic lung physiology. Perfusion lung scintigraphy
makes use of 99’Technetium-label led macro-aggregates
of albumin (12). These particles are injected intrave-
nously with the patient supine and taking a deep breath,
which guarantees optimal dispersion into the pulmonary
vascular bed, where they become trapped. Only a frac-
tion of the capillaries (in the order of 1 %) are temporarily
obstructed (13). The lungs are imaged in six standard
projections using a camera. Perfusion defects are
identified as areas of hypo- or nonperfusion.
Ventilation scintigraphy is performed by introducing a ‘
radiotracer into the airways. This radiotracer may be a
gas, such as8&dquo;-Krypton or 133 Xenon, or an aerosol that
is labelled with ~~’T~~hnetit~m, such as diethylene tri-
amine penta-acetic acid (DTPA) or carbon (Technegas).
These agents have different characteristics (14). The in-
efl ~ ~ ~Krypton gas has the advantage of a short half-life
and may be used simultaneously with the perfusion scan,
but its costs and availability are limiting factors.
99mTechnetium-labelled aerosols are easier to obtain, but
have the disadvantage of central deposition, which is
especially marked in patients with pulmonary diseases,
resulting in diminished visualisation of the pe~i~h~ral ’
airways. Another inert gas, 133 Xenon, is commonly used
but has the disadvantage that ventilation images have to ’’
be obtained before perfusion scintigraphy. The lungs are
imaged in the same six projections as the perfusion lung ;;
scan. Complications of lung scintigraphy are rare and ;
mainly caused by allergic reactions related to the admin- /
istration of the albumin particles. !
Classification
The classification of lung scan results have been a i
matter of debate for many years. Several attempts were i
made (11,15,16), and one study compared three classifi- i
cations in a group of 96 patients ( ~ ~7~. This study showed !
that the Prospective Investigation of Pulmonary Embo- I I
lism Diagnosis (PIOPED) criteria best predicted the I ’
presence of PE, but was worst in excluding the disease as !
compared with the other two classifications. Subse- ! /
quently, the PIOPED criteria were revised in an attempt /
to improve the exclusion capability, but this led to a
false-negative rate of up to 16% in patients with a tr~~us ~ IIprobability lung scan 18).A more clinically useful classification is to divide the
lung scan results into three categories: 1) a normal per- ! i
fusion scan, indicating the absence of pulmonary embo- !
lism; 2) a high-probability lung scan, defined as one or !
more defects of at least segmental size with normal
matching ventilation, which indicates the presence of I
emboli; and 3) the remaining lung scan results, referred I
to as nondiagnostic scan, which would require further
diagnostic tests (19). In a recent, direct comparison in
570 patients using this simple classification versus the
revised PIOPED criteria, it was shown that the more
complicated PIOPED criteria offer no advantage (20).
Using a variety of classifications, there is about 10 to
20% observer disagreement for lung scan reporting 
I
(21,22). The use of an anatomical lung segment chart is ;
useful, because it improves the intra- and interobserver I
variability of reporting (23). ’ /
Normal lung scan [
The clinical validity of a normal perfusion lung scan
has been documented in three well-designed studies ~~’I-
26). In a total of 693 patients with a normal perfusion
lung scan in whom anticoagulants were withheld, two
patients (0.3%; 959h CI: 0.2-0.4%) had a thromboem- 1
bolic event during a follow-up period of at least 3 /months, one of them fatal. Hence, it is deemed safe tao
withhold anticoagulants in patients with a normal perfu- /
sion lung scan. An exception is the patient with a high ’
clinical suspicion of pulmonary embolism and a normal,




A total of nine studies were identified, which com-
pared a high-probability lung scan (as defitied at least
one segmental mismatch) with pulmonary angiography
(8-11,16,28-31). The positive predictive in 350
patients was 88% (95% Cl: 84.-~ l ~o~. In the majority of
patients, this is sufficient to warrant treatment with an-
ticoagulants. However, one has to remain aware that
other disorders than pulmonary embolism can cause per-
fusion-ventilation mismatch (32). Therefore, in patients
who have an increased bleeding risk, it may be necessary
to perform pulmonary angiography after all.
Nondiagnostic lung scan
Using a three-result classification, a total of 12 studies,
were identified that compared a nondiagnostic lung scan
with pulmonary angiography (8-11,16,33-35). Pulmo-
nary emboli were demonstrated in 385 of 1529 patients
~~5~,~; 95% Cl: 24-~8~’n}. Therefore, a nondiagnostic
lung scan result can suggest one management decision
only: further diagnostic tests are required.
Helical computed tomography
T~c ~t~i~u~
. The technique of helical (or spiral) CT first was ap-
plied for the diagnosis of pulmonary embolism in pa-
tients, by Remy-Jardin et al. in !992 (36). Briefly, helical
computed tomography (hCT) is using radiograms similar
to conventional CT, but hCT moves the patient through
the scanner during imaging. This results in a helical mo-
tion of the radiograph tube around the patient. During
scanning, intravenous contrast material is injected with
an aim to opacify the pulmonary arterial tree. The ob-
tained (volumetric) data can be reconstructed in trans-
verse and multiplanar fashion.
C~M~ca~o~ 
’
Similar to pulmonary angiography, pulmonary emboli
seen during hCT are defined as intraluminal filling de-
fects or complete nonfilling of a pulmonary arterial
branch (36). Although many different patterns of addi-
tional signs have been described, these have not been
shown helpful in identifying patients with or without
PE(37,38).
The interobserver variations has been investigated in
several studies (~9~41 ~. The observer agreement, as
shown by K statistic, was high in all studies. How- ‘
ever, more disagreement consisted in patients with
previous nondiagnostic lung scans and in smaller pulmo-
nary emboli, raising the issue of sensitivity in subseg-
mental PE (39,41). The sensitivity in this subgroup
dropped from approximately 90 to 67% (39). This is
an important issue, as up to 30% of patients with sus-




Initial studies assessed the accuracy of helical CT
in patients with (suspected) massive or central PE. The
first study by Remy-Jardin in a selected series of 18
patients with central PE showed a sensitivity and speci-
ficity of 100% (36). Subsequently, a total of 12 studies
assessed sensitivity and specificity using lung scintigra-
phy (45), pulmonary angiography ~~:6-~-5 ~’) or a combi-
nation of lung scintigraphy and pulmonary angiography
(39,40,52-54) as reference method. These studies are
summarized in Table 1. The overall sensitivity and speci-
ficity are 88% (95% Cl: 83-9!%) and 92% (95% Cl:
8~-~~~lo), respectively.
The high prevalence in some of these studies indicates
that they were more focused on central PE, which may
influence the overall figures. Several studies evaluated
TABLE 1. Summary of studies assessing ~ .y~M~M~y and ~gc~c~fy cf~p~~ computed tomographic (CT) a~~~ap~y~r
the diagnosis <~’pMfmWMfy embolism (PE)
* Angiography in 26 patients; follow-up in 28 patients. tCT only in 77 patients with non-normal perfusion scintigraphy; angiography in 42 patients
with non-diagnostic lung scan and in 3 patients with high probability lung scan and normal spiral CT. tCT in all 149 patients: PE excluded by
perfusion scan (40) or angiogram (41); PE proven by high probability scan (53) or angiogram (15).
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the influence of embolus size on sensitivity and speci-
ficity (39,48,49). This revealed that the sensitivity is
markedly lower for subsegmental PE, and appears to be
in the range of 50 to 65% (39,48,49).
Another important issue is the number of technically
inadequate helical CT investigations. This ranged be-
tween 3 and 6% (40,51,52,54). More recent studies have
shown that these figures can be improved further. Using
smaller collimation of 2 mm (55) and multiplanar recon-
struction algorithms (56) can further improve visualiza-
tion of segmental and even subsegmental arteries. Thus,
the current accuracy figures may be further improved on
with the implementation of better imaging protocols.
Management studies
Only a few studies have evaluated the outcome of
patients with suspected pulmonary embolism in which
helic~.t CT played a role in management. One prospective
management study in 164 patients with nondiagnostic
lung scan findings and normal duplex ultrasonography of
the leg veins made use of hCT (57). This study showed
PE in 39 (24%) patients, who were promptly treated with
anticoagulants therapy. Angiography was performed in 15
patients with normal hCT findings caused by high clitii-
cal suspicion, and this showed PE in one patient. Three
months follow-up was obtained in the 109 patients with
a norman hCT study, who did not receive anticoagulant
therapy based on a normal hCT study. One patient died
because of recurrent PE, two developed nonfatal recur-
rent PE, and three were diagnosed with unexplained
deep-vein thrombosis (one further patient suffered local
thrombosis following angiography). Thus, recurrent
thromboembolic events occurred in 5.5% of patients
(95% Cl: 2-=12~~~, with a 1% fatality rate (9~~1~ CI: 0.02-
4.3%). These results compare unfavorably with those of
management studies, which used lung scintigraphy and
pulmonary angiography (58-60).
A second study consisted of a retrospective review of
126 patients who had hCT during the course of their
management (~ I ~. Six months follow-up was complete in
78 patients with a n~~n~.l hCT who remained untreated.
None of these patients died of recurrent PE, and autopsy
revealed small PE in only one patient. For comparison, a
dp c~~ ~f~ pa~i~nts ~ith nc~rcna~. p~ i~n ~~inti p~y -grou of 46 t e w o m l erfusion sc ntigraphy
showed no recurrent PE, but in a group of 132 patient
with low probability two fatal and one nonfatal embolic
events were recorded.
Finally, another retrospective review of 143 patients
who underwent hCT for suspected PE was carried out
(62). Six months follow-up was aimed for in 113 patients
with normal hCT patients who remained untreated. Dur-
ing follow-up, contact with 13 patients was lost and 19
died (none reportedly from PE), whereas no recurrent PE
was documented in the remaining 81 patients.
DISCUSSION
Lung scintigraphy has been well evaluated. For patient
management, two results are sufficient: a normal perfu-
scion scan adequately excludes PE, whereas a high
probability scan result is sufficient proof to warrant an-
ticoagulant therapy in most patients. Nevertheless, one
needs to be aware that PE may be absent in as many as
12% of patients with a high-probability lung scan result.
Helical CT is a newer technique that has not been fully
evaluated yet. The results are promising, and there is ;
some evidence that hCT can replace (in part) lung scin- /
tigraphy. If thrombus is evident at hCT, this is sufficient
to warrant anticoagulant therapy. In patients with sus- i
pected PE and normal hCT findings, however, further
diagnostic work-up is required. Some have suggested i
that alternative findings during hCT, such as at~l~ctasis, ; i
tumor, or pleural effusion in the absence of PE may
adequately exclude PE and that patients could remain j
without anticoagulant therapy. However, a recent ‘study
suggested that alternative findings are equally present
in those with and without PE (38). Furthermore, nor
prospective management studies exist to support this I
notion. Thus, at present, it should be regarded unsafe to I
withhold anticoagulant therapy in patients with normal
hCT findings. !
What could be the role of hCT in the future? Although t
the exact role of hCT has not been fully established, it is !
expected that it will play a significant role in the future I
management of patients with suspected PE. This is not .!
only because of its diagnostic accuracy, but also because
of its noninvasive nature and the wide availability. A
diagnostic strategy using hCT should try to increase the
prevalence of PE in patients before referral for hCT. A
combination with plasma D-dimer testing and venous
ultrasonography seems a good way forward, as recently I
demonstrated in a large management study (63). In this
study, 47% of patients either had PE excluded by D-
dimer of proven by ultrasonography. In the re~na~ning :
53% of patients, the prevalence of PE was 25%. At this
point in the management strategy, one could either per-
form perfusion lung scintigraphy (with 8% of patients
n~rm~l~, leaving 39% of patients for hCT (with a preva-
lence of PE of 3~~~~: Alternatively, one could perform
hCT in all 53% of patients and leave out lung scintigra-
phy altogether. Findly, clinical probability should be
taken into consideration if hCT does not show PE. If the
clinical probability is low, one could withhold antico-
agulant therapy, whereas pulmonary angiography would
be required in the 5-t0% of patients with a normal hCT
and a high clinical probability of PE. It should be reit-
erated, that hCT should not be used in routine manage-
ment of patients with suspected PE until the results of
ongoing (and future) prospective management studies I
show its safety and utility. .
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